SavedAdd your journal

Journals / KONURALP TIP DERGİSİ / 2022 / Cilt: 14 - Sayı: 3

The Clinical Correlations of Fatigue in Patients with Sarcoidosis

Sarkoidoz Hastalarında Yorgunluğu Etkileyen Klinik Etkenler

Pınar YILDIZ GÜLHAN
Ege GÜLEÇ BALBAY
Merve ERÇELİK
Ali ANNAKKAYA
Peri ARBAK
Özlem ÖZDEMİR KUMBASAR
Pages
497–502
Publication Date
2022-10-20
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When compared to FAS score

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Fatigue is considered a frequent and characteristic feature of sarcoidosis.
📊
Key Findings & Data:Methods: A total of 56 sarcoidosis patients were included.
💡
Conclusion & Impact:When compared to FAS score
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Sarkoidoz · Yorgunluk değerlendirme ölçeği (YDÖ) · yorgunluk

Abstract

Objective: Fatigue is considered a frequent and characteristic feature of sarcoidosis. This study was designed to determine the prevalence of fatigue in patients with sarcoidosis and to determine its potential clinical correlations in relation to symptom severity. Methods: A total of 56 sarcoidosis patients were included. Data on patient demographics, anthropometrics, disease characteristics, pulmonary function tests, 6-min walking distance (6MWD), blood biochemistry and hemogram findings were retrieved from hospital records. Psychometric instruments involved the fatigue assessment scale (FAS), Beck Depression Inventory (BDI) and Short Form-36 (SF-36) for health-related QOL (HRQOL). Results: Mean±SD patient age was 50.9±11.9 years. Of 56 patients, 44 were females and 12 were males. When compared to FAS score

Özet

Amaç: Yorgunluk, sarkoidozun sık ve karakteristik bir özelliği olarak kabul edilir. Bu çalışma, sarkoidozlu hastalarda yorgunluk prevalansını belirlemek ve semptom şiddeti ile ilişkili potansiyel klinik korelasyonlarını belirlemek için tasarlanmıştır. Gereç ve Yöntem: Toplam 56 sarkoidoz hastası dahil edildi. Hastane kayıtlarından hasta demografisi, antropometri, hastalık özellikleri, solunum fonksiyon testleri, 6 dakikalık yürüme mesafesi (6DYM), kan biyokimyası ve hemogram bulgularına ilişkin veriler elde edildi. Psikometrik araçlar, sağlıkla ilgili yaşam kalitesi (HRQOL) için yorgunluk değerlendirme ölçeği (FAS), Beck Depresyon Ölçeği (BDÖ) ve Kısa Form-36 (SF-36) kullanıldı. Bulgular: Ortalama ± SS hasta yaşı 50.9 ± 11.9 yıldı. 56 hastanın 44'ü kadın, 12'si erkekti. FAS skoru

🔖

Cite This Article

GÜLHAN, P. Y., BALBAY, E. G., ERÇELİK, M., ANNAKKAYA, A., ARBAK, P., KUMBASAR, Ö. Ö. (2022). The Clinical Correlations of Fatigue in Patients with Sarcoidosis. KONURALP TIP DERGİSİ, Cilt: 14 - Sayı: 3, 497–502. https://ajindex.com/articles/686626

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Hunninghake G.W, Costabel U, Ando M, Baughman R, Cordier, J.F, du Bois R et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc. Diffuse Lung Dis. 1999;16(2):149-73
  2. Yıldız Gülhan P, Güleç Balbay E, Erçelik M, Yıldız Ş, Yılmaz MA. Is sarcoidosis related to metabolic syndrome and insulin resistance? Aging Male. 2020. 23 (1), 53-8
  3. Bahmer T, Watz H, Develaska M, Waschki B, Rabe KF, Magnussen H et al. Physical Activity and Fatigue in Patients with Sarcoidosis. Respiration. 2018;95(1):18–26
  4. Strookappe B, De Vries J, Elfferich M, Kuijpers P, Knevel T, Drent M: Predictors of fatigue in sarcoidosis: the value of exercise testing. Respir Med. 2016;116:49-54
  5. Cho PSP, Vasudevan S, Maddocks M, Spinou A, Chamberlain Mitchell S, Wood C et al. Physical Inactivity in Pulmonary Sarcoidosis. Lung. 2019 Jun;197(3):285-93
  6. Górski W, Piotrowski WJ. Fatigue syndrome in sarcoidosis. Pneumonol Alergol Pol. 2016; 84(4):244–50
  7. Michielsen HJ, Drent M, Peros-Golubicic T, De Vries J. Fatigue is associated with quality of life in sarcoidosis patients. Chest 2006;130:989–94
  8. Drent M, Lower EE, De Vries J. Sarcoidosis-associated fatigue. Eur Respir J. 2012;40(1):255-263
  9. De Vries J, Michielsen H, Van Heck GL, Drent M. Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS). Br J Health Psychol 2004;9(Pt 3):279–91
  10. Beck AT. An inventory for measuring depression. Arch Gen Psychiatry.1961;4:561-71
  11. Górski W, Mokros Ł, Kumor-Kisielewska A, Pietras T, Piotrowski WJ. The utility of selected questionnaires in the assessment of fatigue, depression and health quality in post-sarcoidosis fatigue syndrome. Adv Respir Med 2017;85(6):313-21
  12. Goracci A, Fagiolini A, Martinucci M, Calossi S, Rossi S, Santomauro T, et al. Quality of life, anxiety and depression in sarcoidosis. Gen Hosp Psychiatry.2008;30(5):441–445
  13. Kleijn WPE, Drent M, De Vries J. Nature of fatigue moderates depressive symptoms and anxiety in sarcoidosis. Br J Health Psychol. 2013;18(2):439–52
  14. Chang B, Steimel J, Moller DR, Baughman RP, Judson MA, Yeager H Jr, et al. Depression in sarcoidosis. Am J Respir Crit Care Med. 2001;163(2):329–34
  15. Wirnsberger RM, de Vries J, Wouters EF, Drent M. Clinical presentation of sarcoidosis in the Netherlands: an epidemiological study. Neth J Med. 1998;53(2):53–60
  16. De Vries J, Van Heck GL, Drent M.